S0217, Adjuvant Cisplatin and Docetaxel After Complete Resection Stage III or IV Head and Neck Cancer
Status:
Withdrawn
Trial end date:
2007-01-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy, such as cisplatin and docetaxel, work in different
ways to stop tumor cells from dividing so they stop growing or die. Radiation therapy uses
high-energy x-rays to damage tumor cells. Cisplatin and docetaxel may make the tumor cells
more sensitive to radiation therapy. Giving chemoradiotherapy after surgery may kill any
remaining tumor cells.
PURPOSE: This phase II trial is studying how well adjuvant chemoradiotherapy using cisplatin
and docetaxel works in treating patients with completely resected stage III or stage IV head
and neck cancer.